These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1828421)

  • 1. Technetium 99m mercaptoacetyltriglycine gamma camera clearance calculations: methodological problems.
    Tondeur M; Piepsz A; Dobbeleir A; Ham H
    Eur J Nucl Med; 1991; 18(2):83-6. PubMed ID: 1828421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples.
    Gordon I; Anderson PJ; Orton M; Evans K
    J Nucl Med; 1991 Sep; 32(9):1704-8. PubMed ID: 1831838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
    Sohaib M; Rafique A; Saeed S; Afshan A
    Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of technetium-99m-MAG3 plasma clearance in adults from one or two blood samples.
    Russell CD; Taylor A; Eshima D
    J Nucl Med; 1989 Dec; 30(12):1955-9. PubMed ID: 2531219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of 99mTc-mercaptoacetyltriglycine in captopril renography.
    Taylor A; Martin LG
    Am J Hypertens; 1991 Dec; 4(12 Pt 2):731S-736S. PubMed ID: 1837994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteers.
    Bormans GM; Cleynhen BJ; De Roo MJ; Verbruggen AM
    Eur J Nucl Med; 1992; 19(4):271-7. PubMed ID: 1534544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
    Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
    J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.
    Müller-Suur R; Magnusson G; Bois-Svensson I; Jansson B
    Eur J Nucl Med; 1991; 18(1):28-31. PubMed ID: 1826882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
    Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
    Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
    Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY
    Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of renal function with a count-based gamma camera method using technetium-99m-MAG3 in children.
    Itoh K; Nonomura K; Yamashita T; Kanegae K; Murakumo M; Koyanagi T; Furudate M
    J Nucl Med; 1996 Jan; 37(1):71-5. PubMed ID: 8544005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
    Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
    Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal maturation on the clearance of technetium-99m mercaptoacetyltriglycine.
    Lythgoe MF; Gordon I; Anderson PJ
    Eur J Nucl Med; 1994 Dec; 21(12):1333-7. PubMed ID: 7875172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of renal function from 99mTc-MAG3 renography without blood sampling.
    Inoue Y; Ohtake T; Yokoyama I; Yoshikawa K; Asai S; Ohtomo K
    J Nucl Med; 1999 May; 40(5):793-8. PubMed ID: 10319752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance in patients with impaired renal function.
    Erdil TY; Dede F; Tuglular S; Sen F; Ones T; Farsakoglu Z; Inanir S; Ozener C; Akoglu E; Turoglu T
    Nucl Med Commun; 2006 Feb; 27(2):191-6. PubMed ID: 16404234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
    Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
    J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.